← Leaderboards
Nathan K. Archer
Johns Hopkins University
$3,345,397
Attributed
$5,095,299
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2018–24$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,095,299 · 4
By mechanism
R01$4,920,917 · 3
K01$174,382 · 1
Top collaborators
- M. Javad Aman4 shared
- Hatice Karauzum1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Young J. Kim$4,039,490
- Lisa Ann Beck$6,300,345
- Sean X Leng$11,597,269
- Stanley R Hamilton$26,840,413
- Andrea L Cox$41,369,991
Others in their field
Other Emerging Leaders on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- James Dale Berry · Brigham And Women'S Hospital$25,538,716
- Ionut Bebu · George Washington University$18,816,779
- Barbara Halina Braffett · George Washington University$18,816,779
- Gary Fanger · Rise Therapeutics, Llc$17,847,765
Research focus
MediatingResponseT Cell ResponseT-LymphocyteInsightImmuneSurfaceWild Type MouseAffectInterleukin-17CytokineStaphylococcus Aureus InfectionStaphylococcus AureusPathogenicityImmunotherapyFutureCutaneousSuperantigensCd4 Positive T LymphocytesInfectionImmune ResponseHumanized MouseExposure ToToxin
Grant awards (11)
Protective versus deleterious immune responses that impact vaccine efficacy against Staphylococcus aureus bloodstream infection$619,311
R01 · FY2024 · AI
Protective versus deleterious immune responses that impact vaccine efficacy against Staphylococcus aureus bloodstream infection$663,570
R01 · FY2023 · AI
Protective versus deleterious immune responses that impact vaccine efficacy against Staphylococcus aureus bloodstream infection$727,487
R01 · FY2022 · AI
IL-36 responses in Staphylococcus aureus driven skin inflammation$356,103
R01 · FY2022 · AR · contact PI
Protective versus deleterious immune responses that impact vaccine efficacy against Staphylococcus aureus bloodstream infection$745,628
R01 · FY2021 · AI
IL-36 responses in Staphylococcus aureus driven skin inflammation$348,909
R01 · FY2021 · AR · contact PI
Protective versus deleterious immune responses that impact vaccine efficacy against Staphylococcus aureus bloodstream infection$743,809
R01 · FY2020 · AI
IL-36 responses in Staphylococcus aureus driven skin inflammation$359,700
R01 · FY2020 · AR · contact PI
STAT3-mediated immunity to Staphylococcus aureus in skin$356,400
R01 · FY2020 · AR · contact PI
The role of IL-1alpha in atopic dermatitis skin inflammation$43,432
K01 · FY2019 · AR · contact PI
The role of IL-1alpha in atopic dermatitis skin inflammation$130,950
K01 · FY2018 · AR · contact PI